Shantell Laketa Heiber

Array ( [id] => 4833324 [patent_doc_number] => 20080131871 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-05 [patent_title] => 'Compositions and methods for identifying antigens which elicit an immune response' [patent_app_type] => utility [patent_app_number] => 11/896337 [patent_app_country] => US [patent_app_date] => 2007-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 30523 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20080131871.pdf [firstpage_image] =>[orig_patent_app_number] => 11896337 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5473054 [patent_doc_number] => 20090246220 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'CONSTRUCTS FOR ENHANCING IMMUNE RESPONSES' [patent_app_type] => utility [patent_app_number] => 12/438889 [patent_app_country] => US [patent_app_date] => 2007-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 21574 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20090246220.pdf [firstpage_image] =>[orig_patent_app_number] => 12438889 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6477534 [patent_doc_number] => 20100285058 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'DNA VACCINE FOR TREATING OR PREVENTING CERVICAL CANCER COMPRISING A GENE ENCODING HPV PROTEIN' [patent_app_type] => utility [patent_app_number] => 11/995624 [patent_app_country] => US [patent_app_date] => 2007-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 5665 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0285/20100285058.pdf [firstpage_image] =>[orig_patent_app_number] => 11995624 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4825599 [patent_doc_number] => 20080124702 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-29 [patent_title] => 'Methods of diagnosing cervical cancer' [patent_app_type] => utility [patent_app_number] => 11/881724 [patent_app_country] => US [patent_app_date] => 2007-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 42474 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20080124702.pdf [firstpage_image] =>[orig_patent_app_number] => 11881724 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4733420 [patent_doc_number] => 20080050399 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-28 [patent_title] => 'IMMUNE RESPONSES AGAINST HPV ANTIGENS ELICITED BY COMPOSITIONS COMPRISING AN HPV ANTIGEN AND A STRESS PROTEIN OR AN EXPRESSION VECTOR CAPABLE OF EXPRESSION OF THESE PROTEINS' [patent_app_type] => utility [patent_app_number] => 11/828900 [patent_app_country] => US [patent_app_date] => 2007-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 16317 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0050/20080050399.pdf [firstpage_image] =>[orig_patent_app_number] => 11828900 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 204023 [patent_doc_number] => 07628993 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-08 [patent_title] => 'Compositions and methods for vaccinating against HSV-2' [patent_app_type] => utility [patent_app_number] => 11/781153 [patent_app_country] => US [patent_app_date] => 2007-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 58 [patent_figures_cnt] => 56 [patent_no_of_words] => 39508 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/628/07628993.pdf [firstpage_image] =>[orig_patent_app_number] => 11781153 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 363615 [patent_doc_number] => 07482428 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-01-27 [patent_title] => 'Optimized expression of HPV 31 L1 in yeast' [patent_app_type] => utility [patent_app_number] => 11/879905 [patent_app_country] => US [patent_app_date] => 2007-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 8662 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/482/07482428.pdf [firstpage_image] =>[orig_patent_app_number] => 11879905 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4921522 [patent_doc_number] => 20080069837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-20 [patent_title] => 'Composition and method for treating cancer using herpes virus' [patent_app_type] => utility [patent_app_number] => 11/827108 [patent_app_country] => US [patent_app_date] => 2007-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 23105 [patent_no_of_claims] => 102 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20080069837.pdf [firstpage_image] =>[orig_patent_app_number] => 11827108 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5210031 [patent_doc_number] => 20070248615 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-25 [patent_title] => 'T helper cell epitopes' [patent_app_type] => utility [patent_app_number] => 11/812458 [patent_app_country] => US [patent_app_date] => 2007-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 8386 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20070248615.pdf [firstpage_image] =>[orig_patent_app_number] => 11812458 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4758917 [patent_doc_number] => 20080311143 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'CONSTRUCTION OF CHIMERA PRRSV, COMPOSITIONS AND VACCINE PREPARATIONS' [patent_app_type] => utility [patent_app_number] => 11/763822 [patent_app_country] => US [patent_app_date] => 2007-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6330 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20080311143.pdf [firstpage_image] =>[orig_patent_app_number] => 11763822 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5045610 [patent_doc_number] => 20070264283 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-15 [patent_title] => 'VACCINE' [patent_app_type] => utility [patent_app_number] => 11/760127 [patent_app_country] => US [patent_app_date] => 2007-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11656 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20070264283.pdf [firstpage_image] =>[orig_patent_app_number] => 11760127 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 122104 [patent_doc_number] => 07704510 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-27 [patent_title] => 'Cytomegalovirus surface protein complex for use in vaccines and as a drug target' [patent_app_type] => utility [patent_app_number] => 11/810578 [patent_app_country] => US [patent_app_date] => 2007-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 18755 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/704/07704510.pdf [firstpage_image] =>[orig_patent_app_number] => 11810578 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4927836 [patent_doc_number] => 20080167199 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-10 [patent_title] => 'Multimerization of HIV-1 vif protein as a therapeutic target' [patent_app_type] => utility [patent_app_number] => 11/809953 [patent_app_country] => US [patent_app_date] => 2007-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 14107 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20080167199.pdf [firstpage_image] =>[orig_patent_app_number] => 11809953 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4903560 [patent_doc_number] => 20080112973 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'Chimeric papillomavirus-like particles' [patent_app_type] => utility [patent_app_number] => 11/807004 [patent_app_country] => US [patent_app_date] => 2007-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7600 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20080112973.pdf [firstpage_image] =>[orig_patent_app_number] => 11807004 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4778278 [patent_doc_number] => 20080286276 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-20 [patent_title] => 'Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV)' [patent_app_type] => utility [patent_app_number] => 11/802769 [patent_app_country] => US [patent_app_date] => 2007-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28440 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20080286276.pdf [firstpage_image] =>[orig_patent_app_number] => 11802769 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 588286 [patent_doc_number] => 07435547 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-14 [patent_title] => 'Therapeutic agent for fibromyalgia' [patent_app_type] => utility [patent_app_number] => 11/802742 [patent_app_country] => US [patent_app_date] => 2007-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3385 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/435/07435547.pdf [firstpage_image] =>[orig_patent_app_number] => 11802742 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4785032 [patent_doc_number] => 20080138361 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-12 [patent_title] => 'Optimized expression of HPV 45 L1 in yeast' [patent_app_type] => utility [patent_app_number] => 11/805453 [patent_app_country] => US [patent_app_date] => 2007-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8120 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20080138361.pdf [firstpage_image] =>[orig_patent_app_number] => 11805453 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 43212 [patent_doc_number] => 07776537 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-17 [patent_title] => 'Method of preparing a PRRS virus vaccine' [patent_app_type] => utility [patent_app_number] => 11/751560 [patent_app_country] => US [patent_app_date] => 2007-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8544 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 147 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/776/07776537.pdf [firstpage_image] =>[orig_patent_app_number] => 11751560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5246928 [patent_doc_number] => 20070243162 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-18 [patent_title] => 'Specific binding agents for KSHV vIL-6 That neutrallize a biological activity' [patent_app_type] => utility [patent_app_number] => 11/803732 [patent_app_country] => US [patent_app_date] => 2007-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 22746 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0243/20070243162.pdf [firstpage_image] =>[orig_patent_app_number] => 11803732 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4485192 [patent_doc_number] => 07883844 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-08 [patent_title] => 'Method for propagating influenza virus' [patent_app_type] => utility [patent_app_number] => 12/300625 [patent_app_country] => US [patent_app_date] => 2007-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 4770 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/883/07883844.pdf [firstpage_image] =>[orig_patent_app_number] => 12300625 [rel_patent_id] =>[rel_patent_doc_number] =>)